PAPPALARDO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 5.282
EU - Europa 2.714
AS - Asia 1.959
SA - Sud America 509
AF - Africa 412
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 8
Totale 10.926
Nazione #
US - Stati Uniti d'America 5.073
SG - Singapore 1.008
IT - Italia 835
CN - Cina 717
IE - Irlanda 595
BR - Brasile 473
UA - Ucraina 383
CI - Costa d'Avorio 309
DE - Germania 194
CA - Canada 184
RU - Federazione Russa 146
FI - Finlandia 135
FR - Francia 87
BE - Belgio 59
SN - Senegal 57
AT - Austria 55
GB - Regno Unito 53
NL - Olanda 41
VN - Vietnam 39
KR - Corea 36
SE - Svezia 32
AU - Australia 28
CZ - Repubblica Ceca 24
IN - India 21
BD - Bangladesh 20
NG - Nigeria 18
IQ - Iraq 15
UZ - Uzbekistan 15
CH - Svizzera 14
ES - Italia 14
NZ - Nuova Zelanda 14
GR - Grecia 12
TR - Turchia 12
JP - Giappone 11
MX - Messico 11
PK - Pakistan 11
AR - Argentina 10
PL - Polonia 10
EU - Europa 8
PT - Portogallo 8
VE - Venezuela 8
LB - Libano 7
ZA - Sudafrica 7
BG - Bulgaria 6
IR - Iran 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
EC - Ecuador 5
HK - Hong Kong 5
HU - Ungheria 5
JM - Giamaica 5
KZ - Kazakistan 5
TN - Tunisia 5
CR - Costa Rica 4
KG - Kirghizistan 4
NP - Nepal 4
EG - Egitto 3
IL - Israele 3
MA - Marocco 3
PE - Perù 3
PS - Palestinian Territory 3
PY - Paraguay 3
BB - Barbados 2
GA - Gabon 2
JO - Giordania 2
KW - Kuwait 2
NO - Norvegia 2
OM - Oman 2
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
ID - Indonesia 1
LV - Lettonia 1
ME - Montenegro 1
MN - Mongolia 1
RO - Romania 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 10.926
Città #
Santa Clara 1.057
Chandler 752
Singapore 604
Dublin 580
Jacksonville 407
Chicago 311
Abidjan 309
Houston 292
Boardman 248
Catania 247
Cambridge 163
Lawrence 159
Andover 152
Nanjing 139
Ashburn 119
Toronto 118
Des Moines 96
Helsinki 94
Civitanova Marche 86
Hefei 80
Nuremberg 80
Brussels 58
San Mateo 58
Dakar 57
Nanchang 56
Wilmington 49
Rome 46
Bremen 42
Council Bluffs 42
The Dalles 39
Hebei 36
Lappeenranta 36
Columbus 35
Shenyang 35
Seoul 34
Beijing 32
Ottawa 31
Saint Petersburg 31
Vienna 30
Jiaxing 29
Dong Ket 28
São Paulo 28
Tianjin 27
Los Angeles 25
Munich 25
Changsha 20
Seattle 20
Brno 19
Falls Church 19
Pozzallo 19
Abuja 18
Belo Horizonte 18
Rio de Janeiro 18
Shanghai 16
Naples 15
Acireale 14
Zhengzhou 14
Norwalk 13
San Giovanni la Punta 13
Grafing 12
Padova 12
L'Île-Saint-Denis 11
Messina 10
Moscow 10
Porto Alegre 10
Washington 10
Amsterdam 9
Mascalucia 9
Redwood City 9
Salvador 9
Palermo 8
Sydney 8
Campinas 7
Den Haag 7
Guangzhou 7
Hanoi 7
Jinan 7
Lanzhou 7
Liberty Lake 7
Maceió 7
Melbourne 7
Milan 7
Montreal 7
Ningbo 7
Redmond 7
San Francisco 7
Taizhou 7
Turin 7
Bari 6
Bologna 6
Edinburgh 6
Guarulhos 6
Manassas 6
Ragusa 6
Tokyo 6
Boston 5
Brasília 5
Espinho 5
Fortaleza 5
Hong Kong 5
Totale 7.544
Nome #
((2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 213
Parallel Pair-Wise Interaction for Multi-Agent Immune Systems Modelling 199
iAtheroSim: atherosclerosis process simulator on smart devices. 112
2DIs: a SBML compliant web platform for the design and modeling of immune system interactions 110
Computational modeling of immunologic response to immune checkpoint inhibitors in COVID-19 patients with and without cancer 108
A MapReduce Based Tool for the Analysis and Discovery of Novel Therapeutic Targets 105
In silico clinical trials: concepts and early adoptions 102
A Credibility Assessment Plan for an In Silico Model that Predicts the Dose-Response Relationship of New Tuberculosis Treatments 97
Computational modelling in melanoma for novel drug discovery 96
R- ed S-LP2: sintesi, molecular docking e valutazione farmacologica 96
Agent based modeling of the immune system: NetLogo, a promising framework 93
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis 93
A multi-step and multi-scale bioinformatic protocol to investigate potential SARS-CoV-2 vaccine targets 91
Boosting multiple sclerosis lesion segmentation through attention mechanism 88
Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis 87
A biological optimization problem on the Grid 87
A MapReduce tool for in-depth analysis of KEGG pathways: identification and visualization of therapeutic target candidates 87
The Potential of Computational Modeling to Predict Disease Course and Treatment Response in Patients with Relapsing Multiple Sclerosis 87
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation 86
Credibility of In Silico Trial Technologies - A Theoretical Framing 86
Combining agent based-models and virtual screening techniques to predict the best citrus-derived vaccine adjuvants against human papilloma virus 85
Gene Silencing of Transferrin-1 Receptor as a Potential Therapeutic Target for Human Follicular and Anaplastic Thyroid Cancer 84
A novel paradigm for cell and molecule interaction ontology: from the CMM model to IMGT-ONTOLOGY 83
A genetic algorithm for shortest path motion problem in three dimensions 82
Abstract 5305: DNA methylation and gene expression in melanoma: A large-scale integrated analysis 81
Toward computational modelling on immune system function 81
Evaluation of the efficacy of RUTI and ID93/GLA-SE vaccines in tuberculosis treatment: in silico trial through UISS-TB simulator 80
SimB16: modeling induced immune system response against B16-melanoma 79
A computational model to predict the immune system activation by citrus derived vaccine adjuvants 79
Agent based modeling of relapsing multiple sclerosis: A possible approach to predict treatment outcome 79
An agent based modeling approach for the analysis of tuberculosis - Immune system dynamics 79
Combining cellular automata and lattice Boltzmann method to model multiscale avascular tumor growth coupled with nutrient diffusion and immune competition 78
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 77
Computational modeling of the expansion of human cord blood CD133+ hematopoietic stem/progenitor cells with different cytokine combinations 77
Nose-to-Brain Drug Delivery and Physico-Chemical Properties of Nanosystems: Analysis and Correlation Studies of Data from Scientific Literature 76
Gene expression and pathway bioinformatics analysis detect a potential predictive value of MAP3K8 in thyroid cancer progression 76
A methodological approach for using High-Level Petri Nets to model the immune system response 75
Agent based simulations in disease modeling Comment on “Towards a unified approach in the modeling of fibrosis: A review with research perspectives” by Martine Ben Amar and Carlo Bianca 74
Optimization of HAART by means of Genetic Algorithms and agent based models of HIV infection 74
PEAK: A Clever Python Tool for Exploratory, Regression, and Classification Data. A Case Study for COVID-19 74
Modeling the competition between lung metastases and the immune system using agents 74
A modeling framework for immune-related diseases 74
Current issues in tumor immunology 73
Advances in Computational Immunology 73
Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS) 73
Computational modeling reveals MAP3K8 as mediator of resistance to vemurafenib in thyroid cancer stem cells 73
Cancer immunoprevention: What can we learn from in silico models? 72
Modelling Vaccine Protocols 72
A model of cytotoxic T antitumor activation stimulated by pulsed dendritic cells 70
Combining Parallel Genetic Algorithms and Machine Learning to Improve the Research of Optimal Vaccination Protocols 70
GPU accelerated analysis of treg-teff cross regulation in relapsing-remitting multiple sclerosis 70
In silico design of recombinant multi-epitope vaccine against influenza A virus 70
Computational modeling of brain pathologies: the case of multiple sclerosis 69
Predictive models in tumor immunology 68
Computational models to predict disease course and treatment response in multiple sclerosis 68
Induction of T cell memory by a dendritic cell vaccine: a computational model 67
Moving forward through the in silico modeling of tuberculosis: a further step with UISS-TB 67
Beyond the state of the art of reverse vaccinology: predicting vaccine efficacy with the universal immune system simulator for influenza 67
Persistence analysis in a Kolmogorov-type model for cancer-immune system competition 66
Analysis of vaccine's schedules using models, 66
Sexual risk behaviours 66
SHyFTA, a Stochastic Hybrid Fault Tree Automaton for the modelling and simulation of Dynamic Reliability problem 65
Agent based modeling of humoral response to atherogenesis 64
Mathematical and computational models in tumor immunology 64
Design and optimization of PEGylated nanoparticles intended for Berberine Chloride delivery 64
Reverse Vaccinology for Influenza A Virus: From Genome Sequencing to Vaccine Design 63
Vaccine protocols optimization: in silico experiences 63
Introducing scale factor adjustments on agent-based simulations of the immune system 63
PETAL: A Python tool for deep analysis of biological pathways 63
Searching of optimal vaccination schedules 62
Computational modelling approaches to vaccinology 62
Translational immunomics of cancer immunoprevention 62
Agent based modeling of lung metastasis-immune system competition 62
BIOESOnet: A Tool for the Generation of Personalized Human Metabolic Pathways from 23andMe Exome Data 62
A computational approach based on the colored Petri net formalism for studying multiple sclerosis 62
Computational models as novel tools for cancer vaccines 62
Using Continuous Petri Nets to predict the impact of microRNA analysis in PI3K/Akt and MAPK Signaling Pathways 61
Modelling Vaccination Schedules for a Cancer Immunoprevention Vaccine 61
The dynamic-to-static conversion of Dynamic Fault Trees using Stochastic Dependency Graphs and Stochastic Activity Networks 61
In silico evaluation of daclizumab and vitamin D effects in multiple sclerosis using agent based models 61
Computational simulations of the immune system for personalized medicine: state of the art and challenges 60
Mathematical modeling of biological systems 60
Compartmental mathematical modeling of immune system - melanoma competition 60
Analysis of vaccine's schedules using models, 60
Generation of digital patients for the simulation of tuberculosis with UISS-TB 60
Advancing PFAS risk assessment: Integrative approaches using agent-based modelling and physiologically-based kinetic for environmental and health safety 59
Optimal vaccination schedules using Simulated Annealing 59
Optimal vaccination schedule search using genetic algorithm over MPI technology 59
A hybrid model of the immune response against lung metastases 59
Computational immunogenetics 59
Cancer vaccines: state of the art of the computational modeling approaches 59
GRIDUISS - A grid based universal immune system simulator framework 58
Modeling biology spanning different scales: An open challenge 58
How can we accelerate COVID-19 vaccine discovery? 58
In silico trials: Verification, validation and uncertainty quantification of predictive models used in the regulatory evaluation of biomedical products 57
Immune system modeling and related pathologies 55
Agent based modeling of atherosclerosis: a concrete help in personalized treatments 55
The combination of artificial intelligence and systems biology for intelligent vaccine design 55
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review) 55
Physio-Environmental Sensing and Live Modeling 54
Totale 7.510
Categoria #
all - tutte 43.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.474


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021754 12 61 96 12 236 34 89 5 81 14 66 48
2021/20221.182 143 158 7 19 190 11 166 49 103 21 44 271
2022/20232.112 183 120 28 251 194 364 12 342 464 18 71 65
2023/20241.514 53 382 73 49 29 230 34 113 14 209 202 126
2024/20254.183 97 602 218 224 921 511 305 145 250 376 258 276
2025/2026205 205 0 0 0 0 0 0 0 0 0 0 0
Totale 11.290